Evaluation of Fluorescence- and Mass Spectrometry–Based CYP Inhibition Assays for Use in Drug Discovery

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 784 citations

Medicine, Pharmacokinetics, Pharmacology +17

The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 437 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450

Charles L. Crespi, Vaughn P. Miller, Bruce W. Penman · Analytical Biochemistry · 1997 · 408 citations

Medicine, Biochemistry, Pharmacology +12

CYP3A4 drug interactions: correlation of 10 <i>in vitro</i> probe substrates

Kenworthy, Bloomer, Houston · British Journal of Clinical Pharmacology · 1999 · 337 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates

David M. Stresser, Andrew P. Blanchard, Stephanie D. Turner et al. · Drug Metabolism and Disposition · 2000 · 276 citations

Medicine, Pharmacokinetics, Pharmacology +17